Eveline J Langereis1, Matthijs M den Os1, Catherine Breen2, Simon A Jones2, Olga C Knaven1, Jean Mercer2, Weston P Miller3, Paula M Kelly4, Jim Kennedy4, Tyler G Ketterl3, Anne O'Meara5, Paul J Orchard3, Troy C Lund3, Rick R van Rijn6, Ralph J Sakkers7, Klane K White8, Frits A Wijburg9. 1. Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center "Sphinx," Academic Medical Center, Amsterdam, the Netherlands. 2. Genetic Medicine, Manchester Academic Health Science Centre, Central Manchester University Hospitals, NHS Foundation Trust, St Mary's Hospital, Manchester, United Kingdom. 3. Division of Pediatric Blood and Marrow Transplantation, University of Minnesota Children's Hospital, Minneapolis, Minnesota. 4. Department of Orthopaedic Surgery, Our Lady's Children's Hospital, Dublin, Ireland. 5. National HSCT Department, Our Lady's Children's Hospital, Dublin, Ireland. 6. Department of Radiology, Academic Medical Center, Amsterdam, the Netherlands. 7. Department of Orthopaedic Surgery, University Medical Center Utrecht, Utrecht, the Netherlands. 8. Department of Orthopedics and Sports Medicine, Seattle Children's Hospital, University of Washington, Seattle, Washington. 9. Department of Pediatric Metabolic Diseases, Emma Children's Hospital and Amsterdam Lysosome Center "Sphinx," Academic Medical Center, Amsterdam, the Netherlands f.a.wijburg@amc.uva.nl.
Abstract
BACKGROUND: Dysostosis multiplex contributes substantially to morbidity in patients with Hurler syndrome (mucopolysaccharidosis type I Hurler phenotype [MPS I-H]), even after successful hematopoietic stem cell transplantation (HSCT). One of the hallmarks of dysostosis multiplex in MPS I-H is hip dysplasia, which often requires surgical intervention. We sought to describe in detail the course of hip dysplasia in this group of patients, as assessed by radiographic analysis, and to identify potential outcome predictors. METHODS: Longitudinal data were obtained from digitally scored pelvic radiographs of patients with MPS I-H using OrthoGon software for parameters including, but not limited to, the acetabular index, migration percentage, Smith ratio, and neck-shaft angle. Scoring was performed independently by two blinded observers. Additional information on genotype, enzyme replacement therapy pre-HSCT, donor chimerism, and enzyme activity post-HSCT were obtained. General trends and potential correlations were calculated with mixed-model statistics. RESULTS: Fifty-two patients (192 radiographs) were included in this analysis. Intraobserver and interobserver variation analysis showed an intraclass correlation coefficient ranging from 0.78 to 1.00. Among the twenty-one patients with follow-up beyond the age of five years, the acetabular index was in the range of severe hip dysplasia in up to 86% of the patients. Severe coxa valga was seen in 91% of the patients. Lateral and superior femoral displacement were highly prevalent, with the migration percentage outside the reference range in up to 96% of the patients. Finally, anterior pelvic tilt increased with age (p = 0.001). No correlations were identified between clinical parameters and radiographic findings. CONCLUSIONS: Our study shows that progressive acetabular dysplasia as well as coxa valga and hip displacement are highly prevalent and progressive over time in patients with MPS I-H, despite successful HSCT. These data may provide essential natural history determinations for the assessment of efficacy of new therapeutic strategies aimed at improving skeletal outcomes in patients with MPS I-H.
BACKGROUND:Dysostosis multiplex contributes substantially to morbidity in patients with Hurler syndrome (mucopolysaccharidosis type I Hurler phenotype [MPS I-H]), even after successful hematopoietic stem cell transplantation (HSCT). One of the hallmarks of dysostosis multiplex in MPS I-H is hip dysplasia, which often requires surgical intervention. We sought to describe in detail the course of hip dysplasia in this group of patients, as assessed by radiographic analysis, and to identify potential outcome predictors. METHODS: Longitudinal data were obtained from digitally scored pelvic radiographs of patients with MPS I-H using OrthoGon software for parameters including, but not limited to, the acetabular index, migration percentage, Smith ratio, and neck-shaft angle. Scoring was performed independently by two blinded observers. Additional information on genotype, enzyme replacement therapy pre-HSCT, donor chimerism, and enzyme activity post-HSCT were obtained. General trends and potential correlations were calculated with mixed-model statistics. RESULTS: Fifty-two patients (192 radiographs) were included in this analysis. Intraobserver and interobserver variation analysis showed an intraclass correlation coefficient ranging from 0.78 to 1.00. Among the twenty-one patients with follow-up beyond the age of five years, the acetabular index was in the range of severe hip dysplasia in up to 86% of the patients. Severe coxa valga was seen in 91% of the patients. Lateral and superior femoral displacement were highly prevalent, with the migration percentage outside the reference range in up to 96% of the patients. Finally, anterior pelvic tilt increased with age (p = 0.001). No correlations were identified between clinical parameters and radiographic findings. CONCLUSIONS: Our study shows that progressive acetabular dysplasia as well as coxa valga and hip displacement are highly prevalent and progressive over time in patients with MPS I-H, despite successful HSCT. These data may provide essential natural history determinations for the assessment of efficacy of new therapeutic strategies aimed at improving skeletal outcomes in patients with MPS I-H.
Authors: Brigitte T A van den Broek; Jaap van Doorn; Charlotte V Hegeman; Stefan Nierkens; Caroline A Lindemans; Nanda Verhoeven-Duif; Jaap Jan Boelens; Peter M van Hasselt Journal: Blood Adv Date: 2020-06-23
Authors: Brigitte T A van den Broek; Caroline A Lindemans; Jaap Jan Boelens; Eveline M Delemarre; Julia Drylewicz; Nanda Verhoeven-Duif; Peter M van Hasselt; Stefan Nierkens Journal: Blood Adv Date: 2021-08-24
Authors: J Do Cao; A Wiedemann; T Quinaux; S F Battaglia-Hsu; L Mainard; R Froissart; C Bonnemains; S Ragot; B Leheup; P Journeau; F Feillet Journal: Mol Genet Metab Rep Date: 2016-10-10
Authors: Gé-Ann Kuiper; Eveline J Langereis; Sandra Breyer; Marco Carbone; René M Castelein; Deborah M Eastwood; Christophe Garin; Nathalie Guffon; Peter M van Hasselt; Pauline Hensman; Simon A Jones; Vladimir Kenis; Moyo Kruyt; Johanna H van der Lee; William G Mackenzie; Paul J Orchard; Neil Oxborrow; Rossella Parini; Amy Robinson; Elke Schubert Hjalmarsson; Klane K White; Frits A Wijburg Journal: Orphanet J Rare Dis Date: 2019-01-18 Impact factor: 4.123
Authors: Troy C Lund; Terence M Doherty; Julie B Eisengart; Rebecca L Freese; Kyle D Rudser; Ellen B Fung; Bradley S Miller; Klane K White; Paul J Orchard; Chester B Whitley; Lynda E Polgreen Journal: JIMD Rep Date: 2020-12-08